Acta Neuropathologica, ISSN 0001-6322, 09/2012, Volume 124, Issue 3, pp. 305 - 323
Here we review the genetic causes and risks for Alzheimer's disease (AD). Early work identified mutations in three genes that cause AD: APP, PSEN1 and PSEN2....
Genetics | Genome-wide association studies | Neuropathology | Alzheimer's disease | APP LOCUS DUPLICATION | AMYLOID PRECURSOR PROTEIN | PATHOLOGY | APOLIPOPROTEIN-E GENOTYPE | NEUROSCIENCES | COTTON WOOL PLAQUES | CLINICAL NEUROLOGY | PRESENILIN-1 MUTATION | BETA-PROTEIN | HEREDITARY CEREBRAL-HEMORRHAGE | SINGLE-NUCLEOTIDE POLYMORPHISMS | LEWY BODIES | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Amyloid beta-Protein Precursor - genetics | Presenilin-2 - genetics | Apolipoproteins E - genetics | Humans | Brain - pathology | Presenilin-1 - genetics | Polymorphism, Single Nucleotide | Mutation | Alzheimer Disease - genetics | Alzheimer Disease - pathology | Amino acids | Single nucleotide polymorphisms | Analysis | Genomics | Innovations | Neurodegenerative diseases | Cognitive ability | Data processing | Genomes | Single-nucleotide polymorphism | Amyloid precursor protein | Risk factors | Molecular modelling | Reviews | Apolipoprotein E | genomics
Genetics | Genome-wide association studies | Neuropathology | Alzheimer's disease | APP LOCUS DUPLICATION | AMYLOID PRECURSOR PROTEIN | PATHOLOGY | APOLIPOPROTEIN-E GENOTYPE | NEUROSCIENCES | COTTON WOOL PLAQUES | CLINICAL NEUROLOGY | PRESENILIN-1 MUTATION | BETA-PROTEIN | HEREDITARY CEREBRAL-HEMORRHAGE | SINGLE-NUCLEOTIDE POLYMORPHISMS | LEWY BODIES | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Amyloid beta-Protein Precursor - genetics | Presenilin-2 - genetics | Apolipoproteins E - genetics | Humans | Brain - pathology | Presenilin-1 - genetics | Polymorphism, Single Nucleotide | Mutation | Alzheimer Disease - genetics | Alzheimer Disease - pathology | Amino acids | Single nucleotide polymorphisms | Analysis | Genomics | Innovations | Neurodegenerative diseases | Cognitive ability | Data processing | Genomes | Single-nucleotide polymorphism | Amyloid precursor protein | Risk factors | Molecular modelling | Reviews | Apolipoprotein E | genomics
Journal Article
2.
Full Text
GWAS of cerebrospinal fluid tau levels identifies risk variants for alzheimer's disease
Neuron, ISSN 0896-6273, 04/2013, Volume 78, Issue 2, pp. 256 - 268
Cerebrospinal fluid (CSF) tau, tau phosphorylated at threonine 181 (ptau), and Aβ are established biomarkers for Alzheimer@s disease (AD) and have been used as...
BIOMARKERS | DIAGNOSIS | PROTEIN | PHOSPHORYLATION | CSF | A-BETA | NEUROPATHOLOGY | ASSOCIATION | EXPRESSION | NEUROSCIENCES | SINGLE-NUCLEOTIDE POLYMORPHISMS | Phosphorylation | Humans | Middle Aged | Male | Case-Control Studies | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Genome-Wide Association Study | Peptide Fragments - cerebrospinal fluid | Risk Factors | Genotype | tau Proteins - cerebrospinal fluid | Transcription Factors - genetics | Alzheimer Disease - cerebrospinal fluid | Serine - metabolism | Chromosomes, Human, Pair 6 - genetics | Membrane Glycoproteins - genetics | Muscle Proteins - genetics | Phenotype | Apolipoproteins E - genetics | Polymorphism, Single Nucleotide - genetics | Aged | Alzheimer Disease - genetics | Receptors, Immunologic - genetics | Chromosomes, Human, Pair 3 - genetics | Alzheimer's disease | Risk factors | Amyloid beta-protein | Studies | Biomarkers | Genomes | Alzheimers disease | Religious orders
BIOMARKERS | DIAGNOSIS | PROTEIN | PHOSPHORYLATION | CSF | A-BETA | NEUROPATHOLOGY | ASSOCIATION | EXPRESSION | NEUROSCIENCES | SINGLE-NUCLEOTIDE POLYMORPHISMS | Phosphorylation | Humans | Middle Aged | Male | Case-Control Studies | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Genome-Wide Association Study | Peptide Fragments - cerebrospinal fluid | Risk Factors | Genotype | tau Proteins - cerebrospinal fluid | Transcription Factors - genetics | Alzheimer Disease - cerebrospinal fluid | Serine - metabolism | Chromosomes, Human, Pair 6 - genetics | Membrane Glycoproteins - genetics | Muscle Proteins - genetics | Phenotype | Apolipoproteins E - genetics | Polymorphism, Single Nucleotide - genetics | Aged | Alzheimer Disease - genetics | Receptors, Immunologic - genetics | Chromosomes, Human, Pair 3 - genetics | Alzheimer's disease | Risk factors | Amyloid beta-protein | Studies | Biomarkers | Genomes | Alzheimers disease | Religious orders
Journal Article
Brain, ISSN 0006-8950, 12/2015, Volume 138, Issue 12, pp. 3673 - 3684
The identification of subjects at high risk for Alzheimer's disease is important for prognosis and early intervention. We investigated the polygenic...
Alzheimer's disease | polygenic score | predictive model | PARKINSON DISEASE | SCHIZOPHRENIA | LOCI | CLU | NEUROSCIENCES | CLINICAL NEUROLOGY | CD2AP | IDENTIFIES VARIANTS | EPHA1 | ONSET | CD33 | GENOME-WIDE ASSOCIATION | Multifactorial Inheritance - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Genetic Testing | Humans | Genotype | Logistic Models | Risk | Case-Control Studies | Apolipoproteins E - genetics | Alleles | ROC Curve | Genetic Variation - genetics | Alzheimer Disease - genetics
Alzheimer's disease | polygenic score | predictive model | PARKINSON DISEASE | SCHIZOPHRENIA | LOCI | CLU | NEUROSCIENCES | CLINICAL NEUROLOGY | CD2AP | IDENTIFIES VARIANTS | EPHA1 | ONSET | CD33 | GENOME-WIDE ASSOCIATION | Multifactorial Inheritance - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Genetic Testing | Humans | Genotype | Logistic Models | Risk | Case-Control Studies | Apolipoproteins E - genetics | Alleles | ROC Curve | Genetic Variation - genetics | Alzheimer Disease - genetics
Journal Article
PLoS Genetics, ISSN 1553-7390, 04/2018, Volume 14, Issue 4, p. e1007306
Improving accuracy in genetic studies would greatly accelerate understanding the genetic basis of complex diseases. One approach to achieve such an improvement...
METAANALYSIS | VARIANTS | GENOTYPE IMPUTATION | ALZHEIMERS-DISEASE | GENETICS & HEREDITY | LOCI | MUTATIONS | EXPRESSION | IMPLICATE | ONSET | GENOME-WIDE ASSOCIATION | Genome-Wide Association Study | Reproducibility of Results | Datasets as Topic | Humans | Risk Factors | Alzheimer Disease - metabolism | Support Vector Machine | Alzheimer Disease - genetics | Protein Interaction Maps | Genome-wide association studies | Research | Genetic susceptibility | Methods | Laboratories | Funding | Genomics | Genomes | Epidemiology | Risk factors | Datasets | Proteins | Consortia | Genotype & phenotype | Aging | Genetics | Bioinformatics | Alzheimer's disease | Supervision | Public health | Immune response | Neurodegenerative diseases | Medicine | Studies | Acids | Replication | Alzheimers disease | Health risk assessment | PTPN2 protein
METAANALYSIS | VARIANTS | GENOTYPE IMPUTATION | ALZHEIMERS-DISEASE | GENETICS & HEREDITY | LOCI | MUTATIONS | EXPRESSION | IMPLICATE | ONSET | GENOME-WIDE ASSOCIATION | Genome-Wide Association Study | Reproducibility of Results | Datasets as Topic | Humans | Risk Factors | Alzheimer Disease - metabolism | Support Vector Machine | Alzheimer Disease - genetics | Protein Interaction Maps | Genome-wide association studies | Research | Genetic susceptibility | Methods | Laboratories | Funding | Genomics | Genomes | Epidemiology | Risk factors | Datasets | Proteins | Consortia | Genotype & phenotype | Aging | Genetics | Bioinformatics | Alzheimer's disease | Supervision | Public health | Immune response | Neurodegenerative diseases | Medicine | Studies | Acids | Replication | Alzheimers disease | Health risk assessment | PTPN2 protein
Journal Article
PLoS genetics, ISSN 1553-7390, 12/2018, Volume 14, Issue 12, p. e1007791
The ApoE ε4 allele is the most significant genetic risk factor for late-onset Alzheimer disease. The risk conferred by ε4, however, differs across populations,...
Genetics, Population | Genome-Wide Association Study | Hispanic Americans - genetics | Puerto Rico - ethnology | Apolipoprotein E4 - genetics | Gene Frequency | Humans | Risk Factors | African Americans - genetics | Male | Case-Control Studies | Genetic Variation | Aged, 80 and over | Female | Aged | Alzheimer Disease - genetics | Funding | Genomics | African Americans | Genomes | Epidemiology | Population genetics | Risk factors | Consortia | Apolipoprotein E | Aging | Genetics | Genetic factors | Alzheimer's disease | Genotypes | Departments | Neurodegenerative diseases | Principal components analysis | Environmental factors | Genetic diversity | Apolipoproteins | Generalized linear models | Medicine | Neurology | Alleles | Surgeons | Psychiatry
Genetics, Population | Genome-Wide Association Study | Hispanic Americans - genetics | Puerto Rico - ethnology | Apolipoprotein E4 - genetics | Gene Frequency | Humans | Risk Factors | African Americans - genetics | Male | Case-Control Studies | Genetic Variation | Aged, 80 and over | Female | Aged | Alzheimer Disease - genetics | Funding | Genomics | African Americans | Genomes | Epidemiology | Population genetics | Risk factors | Consortia | Apolipoprotein E | Aging | Genetics | Genetic factors | Alzheimer's disease | Genotypes | Departments | Neurodegenerative diseases | Principal components analysis | Environmental factors | Genetic diversity | Apolipoproteins | Generalized linear models | Medicine | Neurology | Alleles | Surgeons | Psychiatry
Journal Article
PLOS ONE, ISSN 1932-6203, 07/2019, Volume 14, Issue 7, p. e0218111
Late onset Alzheimer’s disease is the most common form of dementia for which about 30 susceptibility loci have been reported. The aim of the current study is...
Energy metabolism | Neurosciences | Laboratories | Genomics | Genes | DNA damage | Psychotherapy | Genomes | Single-nucleotide polymorphism | Nucleotides | DNA repair | Gene polymorphism | Consortia | Proteins | Neurodegeneration | Dementia disorders | Genetics | Life sciences | Lipid metabolism | Genotypes | Deoxyribonucleic acid--DNA | Public health | Plaques | Circadian rhythms | Medical research | Signs and symptoms | Centrosomes | Rhythm | Metabolism | Gene expression | Loci | Cholesterol | Medicine | Neurology | Hospitals | Councils | Psychiatry | Polymorphism | Dementia | Deoxyribonucleic acid | DNA
Energy metabolism | Neurosciences | Laboratories | Genomics | Genes | DNA damage | Psychotherapy | Genomes | Single-nucleotide polymorphism | Nucleotides | DNA repair | Gene polymorphism | Consortia | Proteins | Neurodegeneration | Dementia disorders | Genetics | Life sciences | Lipid metabolism | Genotypes | Deoxyribonucleic acid--DNA | Public health | Plaques | Circadian rhythms | Medical research | Signs and symptoms | Centrosomes | Rhythm | Metabolism | Gene expression | Loci | Cholesterol | Medicine | Neurology | Hospitals | Councils | Psychiatry | Polymorphism | Dementia | Deoxyribonucleic acid | DNA
Journal Article
PLOS ONE, ISSN 1932-6203, 07/2019, Volume 14, Issue 7, p. e0218111
Late onset Alzheimer's disease is the most common form of dementia for which about 30 susceptibility loci have been reported. The aim of the current study is...
COMMON VARIANTS | IMMUNITY | PGC-1-ALPHA | ANNOTATION | MULTIDISCIPLINARY SCIENCES | ALPHA | GENERATION | DIFFERENTIATION | ZNF423 | BRAIN | CD2AP | Genome-wide association studies | Genes | Genetic aspects | Single nucleotide polymorphisms | Alzheimer's disease | Health aspects | Identification and classification
COMMON VARIANTS | IMMUNITY | PGC-1-ALPHA | ANNOTATION | MULTIDISCIPLINARY SCIENCES | ALPHA | GENERATION | DIFFERENTIATION | ZNF423 | BRAIN | CD2AP | Genome-wide association studies | Genes | Genetic aspects | Single nucleotide polymorphisms | Alzheimer's disease | Health aspects | Identification and classification
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 10/2019, Volume 72, Issue 1, pp. 301 - 318
Most of the loci identified by genome-wide association studies (GWAS) for late-onset Alzheimer’s disease (LOAD) are in strong linkage disequilibrium (LD) with...
Target recognition | Statistical analysis | Downstream effects | Genes | Genomics | Linkage disequilibrium | Genetic diversity | Ribonucleic acid--RNA | Gene expression | Tissues | Loci | Biological activity | Genetic variance | Enhancers | Biological effects | Algorithms | Molecular modelling | Apolipoprotein E | Regulatory mechanisms (biology) | Localization | Bayesian analysis
Target recognition | Statistical analysis | Downstream effects | Genes | Genomics | Linkage disequilibrium | Genetic diversity | Ribonucleic acid--RNA | Gene expression | Tissues | Loci | Biological activity | Genetic variance | Enhancers | Biological effects | Algorithms | Molecular modelling | Apolipoprotein E | Regulatory mechanisms (biology) | Localization | Bayesian analysis
Journal Article
9.
Full Text
Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants
PLOS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185777 - e0185777
The accumulation of amyloid beta (A beta) peptide (Amyloid cascade hypothesis), an APP protein cleavage product, is a leading hypothesis in the etiology of...
NEURONAL APOPTOSIS | GENE | MULTIDISCIPLINARY SCIENCES | TREM2 DEFICIENCY | AMYLOID PRECURSOR PROTEIN | CODING VARIANTS | MISSENSE MUTATIONS | MOUSE MODELS | NON-APOPTOTIC ROLES | CELL-DEATH | BETA | Genetic Predisposition to Disease | Genetic Association Studies | Gene Frequency | Humans | Caspase 8 - metabolism | Case-Control Studies | Caspase 8 - genetics | Genetic Variation | Alleles | Alzheimer Disease - metabolism | Cell Line, Tumor | Neurons - metabolism | Alzheimer Disease - genetics | Care and treatment | Genes | Nervous system | Degeneration | Research | Alzheimer's disease | Risk factors | Index Medicus
NEURONAL APOPTOSIS | GENE | MULTIDISCIPLINARY SCIENCES | TREM2 DEFICIENCY | AMYLOID PRECURSOR PROTEIN | CODING VARIANTS | MISSENSE MUTATIONS | MOUSE MODELS | NON-APOPTOTIC ROLES | CELL-DEATH | BETA | Genetic Predisposition to Disease | Genetic Association Studies | Gene Frequency | Humans | Caspase 8 - metabolism | Case-Control Studies | Caspase 8 - genetics | Genetic Variation | Alleles | Alzheimer Disease - metabolism | Cell Line, Tumor | Neurons - metabolism | Alzheimer Disease - genetics | Care and treatment | Genes | Nervous system | Degeneration | Research | Alzheimer's disease | Risk factors | Index Medicus
Journal Article
BRAIN, ISSN 0006-8950, 09/2019, Volume 142, Issue 9, pp. 2581 - 2589
Autopsy measures of Alzheimer's disease neuropathology have been leveraged as endophenotypes in previous genome-wide association studies (GWAS). However,...
DIAGNOSIS | GUIDELINES | tau | RISK | NEUROSCIENCES | CLINICAL NEUROLOGY | beta-amyloid | NATIONAL INSTITUTE | COGNITIVE DECLINE | genome-wide association study | DISEASE | HAPLOTYPE | Alzheimer's disease | EXPRESSION | neuropathology | GENOME-WIDE ASSOCIATION | Neurosciences | Neurovetenskaper
DIAGNOSIS | GUIDELINES | tau | RISK | NEUROSCIENCES | CLINICAL NEUROLOGY | beta-amyloid | NATIONAL INSTITUTE | COGNITIVE DECLINE | genome-wide association study | DISEASE | HAPLOTYPE | Alzheimer's disease | EXPRESSION | neuropathology | GENOME-WIDE ASSOCIATION | Neurosciences | Neurovetenskaper
Journal Article
Brain, ISSN 0006-8950, 02/2019, Volume 142, Issue 2, pp. 460 - 470
Tan et al. demonstrate that an Alzheimer's disease polygenic hazard score predicts regional amyloid PET deposition and longitudinal cortical atrophy, and is...
cerebrovascular disease | DEMENTIA | RISK PREDICTION | neurodegeneration | RUSH MEMORY | NEUROSCIENCES | CLINICAL NEUROLOGY | amyloid | CORTICAL THICKNESS | CORTEX | COMPOSITE SCORE | polygenic hazard score | Lewy body
cerebrovascular disease | DEMENTIA | RISK PREDICTION | neurodegeneration | RUSH MEMORY | NEUROSCIENCES | CLINICAL NEUROLOGY | amyloid | CORTICAL THICKNESS | CORTEX | COMPOSITE SCORE | polygenic hazard score | Lewy body
Journal Article
ACTA NEUROPATHOLOGICA, ISSN 0001-6322, 12/2018, Volume 136, Issue 6, pp. 857 - 872
Cerebrospinal fluid (CSF) levels of amyloid- 42 (A42) and tau have been evaluated as endophenotypes in Alzheimer's disease (AD) genetic studies. Although there...
SURFACE-BASED ANALYSIS | Alzheimer disease | Neuropathology | Tau | COGNITIVE IMPAIRMENT | RISK | HYPOTHETICAL MODEL | PATHOLOGY | APOLIPOPROTEIN-E GENOTYPE | CEREBROSPINAL-FLUID | Sex difference | NEUROSCIENCES | CLINICAL NEUROLOGY | MEMORY | COMPOSITE SCORE | Cerebrospinal fluid biomarkers | Amyloid | APOE | EXPRESSION | GENOME-WIDE ASSOCIATION | Neurosciences | Neurovetenskaper
SURFACE-BASED ANALYSIS | Alzheimer disease | Neuropathology | Tau | COGNITIVE IMPAIRMENT | RISK | HYPOTHETICAL MODEL | PATHOLOGY | APOLIPOPROTEIN-E GENOTYPE | CEREBROSPINAL-FLUID | Sex difference | NEUROSCIENCES | CLINICAL NEUROLOGY | MEMORY | COMPOSITE SCORE | Cerebrospinal fluid biomarkers | Amyloid | APOE | EXPRESSION | GENOME-WIDE ASSOCIATION | Neurosciences | Neurovetenskaper
Journal Article